New stock dark market | Live eBon pharmaceuticals-B (09637.HK) dark market closed up 94%, landing on the Hong Kong Stock Exchange next Monday.

According to the Smart Finance and Economics APP, today's Hui Li's dark pool trading shows that the "first stock of kidney disease innovation drugs" in Hong Kong stock, Livzon Pharmaceutical-B (09637.HK), closed at 43.88 Hong Kong dollars in the dark pool, up 94.16% from the offering price of 22.60 Hong Kong dollars. Each lot consists of 100 shares, without considering transaction fees, each lot makes a profit of 2128 Hong Kong dollars on the books. It is reported that Livzon Pharmaceutical's IPO has attracted attention from the entire market. The company not only holds a complete pipeline matrix of "1 commercialized product + 7 clinical stage candidate drugs", but also has gathered 11 cornerstone investors spanning global sovereign funds, centennial asset management, professional life science funds, and industrial capital, setting a ceiling for the cornerstone lineup in the A-share market in recent years. Livzon Pharmaceutical will be listed on the Hong Kong Stock Exchange on June 29th (Monday).